Literature DB >> 22879850

Manifestations of systemic lupus erythematosus.

Manole Cojocaru1, Inimioara Mihaela Cojocaru, Isabela Silosi, Camelia Doina Vrabie.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic, multifaceted autoimmune inflammatory disease that can affect any part of the body. SLE is a disease of unknown aetiology with a variety of presenting features and manifestations. Interest in the disease has been stimulated in recent years, and improved methods of diagnosis have resulted in a significant increase in the number of cases recognized. It is apparent that it can no longer be regarded as a rare disease. The majority of the pathology in SLE is related to deposits of immune complexes in various organs, which triggers complement and other mediators of inflammation. Symptoms vary from person to person, and may come and go, depend on what part of the body is affected, can be mild, moderate, or severe. Diagnosis can be difficult because lupus mimics many other diseases; it requires clinical and serologic criteria.

Entities:  

Keywords:  clinical manifestations; laboratory abnormalities; systemic lupus erythematosus

Year:  2011        PMID: 22879850      PMCID: PMC3391953     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  31 in total

1.  Systemic lupus erythematosus and accelerated atherosclerosis.

Authors:  Bevra Hannahs Hahn
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

2.  Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis).

Authors:  C-K Lee; M S Ahn; E Y Lee; J H Shin; Y-S Cho; H K Ha; B Yoo; H-B Moon
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  Musculoskeletal involvement in systemic lupus erythematosus.

Authors:  A Zoma
Journal:  Lupus       Date:  2004       Impact factor: 2.911

4.  Epileptic seizures in systemic lupus erythematosus.

Authors:  Simone Appenzeller; Fernando Cendes; Lilian T L Costallat
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

Review 5.  Ocular manifestations of systemic lupus erythematosus.

Authors:  J Fernando Arevalo; Careen Y Lowder; Rafael Muci-Mendoza
Journal:  Curr Opin Ophthalmol       Date:  2002-12       Impact factor: 3.761

6.  Adaptation to chronic pain in systemic lupus erythematosus: applicability of the multidimensional pain inventory.

Authors:  Carol M Greco; Thomas E Rudy; Susan Manzi
Journal:  Pain Med       Date:  2003-03       Impact factor: 3.750

7.  Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies.

Authors:  David P D'Cruz; Susana Mellor-Pita; Beatriz Joven; Giovanni Sanna; Judith Allanson; James Taylor; Munther A Khamashta; Graham R V Hughes
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

8.  Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures.

Authors:  S Sangle; D P D'Cruz; M A Khamashta; G R V Hughes
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

9.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

Review 10.  Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications.

Authors:  Dan Buskila; Joseph Press; Mahmoud Abu-Shakra
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

View more
  57 in total

Review 1.  Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview.

Authors:  Zijun Wang; Hai Long; Christopher Chang; Ming Zhao; Qianjin Lu
Journal:  Cell Mol Life Sci       Date:  2018-07-04       Impact factor: 9.261

Review 2.  Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective.

Authors:  Ali Javinani; Amir Ashraf-Ganjouei; Saeed Aslani; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Immunogenetics       Date:  2019-01-22       Impact factor: 2.846

Review 3.  The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  Ozan Ünlü; Stephane Zuily; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2015-12-29

4.  Lupus and the Liver: A Case Study.

Authors:  Shaan Patel; Michelle Demory Beckler; Marc M Kesselman
Journal:  Cureus       Date:  2019-08-24

Review 5.  The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis.

Authors:  Natasha K J Campbell; Khalid Saadeldin; Mary A De Vera
Journal:  Curr Rheumatol Rep       Date:  2017-09-18       Impact factor: 4.592

6.  Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.

Authors:  Bethany D Harris; Srilalitha Kuruganti; Ashlesha Deshpande; Paul A Goepfert; W Winn Chatham; Mark R Walter
Journal:  Lupus       Date:  2020-07-01       Impact factor: 2.911

7.  Case report of an acute myocardial infarction complicated by coronary spasm in a patient with chronic systemic lupus erythematosus.

Authors:  Jeanne Lolita Pek; Zhang Jin; Sun Jian
Journal:  Pan Afr Med J       Date:  2021-03-23

8.  The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review.

Authors:  Alessander Leyendecker; Carla Cristina Gomes Pinheiro; Mariane Tami Amano; Daniela Franco Bueno
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

9.  The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States.

Authors:  Ann E Clarke; Jinoos Yazdany; Shaum M Kabadi; Emily Durden; Isabelle Winer; Kirstin Griffing; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2020-05-23       Impact factor: 5.532

Review 10.  [Pathogenesis of systemic lupus erythematosus].

Authors:  S Finzel; S Schaffer; M Rizzi; R E Voll
Journal:  Z Rheumatol       Date:  2018-11       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.